Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

March 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2019. This roundup includes...
Both low and high levels of physical activity are associated with reduced all-cause mortality

Low, High Levels of Physical Activity Tied to Reduced Mortality

All-cause mortality risk lower with 10 to 59 minutes of physical activity per week versus inactivity
Individuals with chronic kidney disease have a modestly elevated cancer risk

Cancer Risk Modestly Elevated With Chronic Kidney Disease

Lower eGFR linked to elevated cancer risk relative to eGFR of 90 to 104 mL/min
Infertility seems to be associated with an increased risk for cancer in women

Infertility in Women Linked to Modestly Elevated Cancer Risk

Overall risk higher for developing cancer; increased risks seen for uterine, ovarian, lung, thyroid cancers
A communication quality-improvement intervention results in better and earlier serious illness conversations

Intervention Promotes Better Conversations With Cancer Patients

But communication quality-improvement intervention does not improve patient outcomes
Precancer psychiatric utilization is associated with worse cancer-specific mortality and all-cause mortality among adults with solid organ malignancies

Prediagnosis Psychiatric Care Linked to Worse Cancer Mortality

Higher cancer-specific, all-cause mortality seen with increasing intensity of prediagnosis psychiatric care
Becoming physically active in middle age may provide comparable health benefits to long-term participation in leisure-time physical activity

Becoming Active in Middle Age Still Offers Health Benefits

Lower risk for all-cause, cardiovascular, cancer-related mortality similar to people active throughout adulthood
There is considerable underdiagnosis of childhood cancer

Childhood Cancer Considerably Underdiagnosed Worldwide

Numbers of undiagnosed cases varied from 3 percent in western Europe to 57 percent in western Africa

February 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2019. This roundup includes...
Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors

Long-Term Cardiomyopathy Risk Varies by Chemo Agent

Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer